SGLT2 Inhibitors Benefit Broad Range of Heart Failure Patients
Risk for cardiovascular death, hospitalization for heart failure reduced regardless of left ventricular ejection fraction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.